CUE — Cue Biopharma, Inc.
Materials · Pharmaceutical Preparations · Nasdaq
7Insiders filing
10Transactions
+$0Reported buys
−$0Reported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Ray Sumita | Chief Legal Compliance Officer | 2 | $0 |
| Lin Shao-Lee | Chief Executive Officer | 2 | $0 |
| Camardo Daniel A. | Director | 1 | $0 |
| Garzone Pamela | Director | 1 | $0 |
| Sarraf Pasha | Director | 1 | $0 |
| Meehan Viola Mong | Director | 1 | $0 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | 2 | $0 |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-09 | CUE | Meluzio Michael Vincent VP, Prin. Accounting Officer | A routine | 40,942 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Meluzio Michael Vincent VP, Prin. Accounting Officer | A routine | 40,942 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Meehan Viola Mong Director | A routine | 21,800 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Sarraf Pasha Director | A routine | 21,800 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Garzone Pamela Director | A routine | 21,800 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Camardo Daniel A. Director | A routine | 21,800 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Lin Shao-Lee Chief Executive Officer | A routine | 327,537 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Lin Shao-Lee Chief Executive Officer | A routine | 327,537 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Ray Sumita Chief Legal Compliance Officer | A routine | 54,589 | — | — | |
| 2026-07-10 | 2026-07-09 | CUE | Ray Sumita Chief Legal Compliance Officer | A routine | 54,589 | — | — |
No transactions match these filters.